151 related articles for article (PubMed ID: 2778805)
1. Inhibition of 3H-quinuclidinyl benzylate binding to cardiac muscarinic receptor by long chain fatty acids can be attenuated by ligand occupation of the receptor.
Rauch B; Colvin RA; Messineo FC
J Mol Cell Cardiol; 1989 May; 21(5):495-506. PubMed ID: 2778805
[TBL] [Abstract][Full Text] [Related]
2. Effect of exogenous phospholipase A2 treatment on cardiac muscarinic receptors of highly purified canine sarcolemmal vesicles.
Rauch B; Colvin RA; Katz AM; Messineo FC
J Mol Cell Cardiol; 1987 Jun; 19(6):569-80. PubMed ID: 3625786
[TBL] [Abstract][Full Text] [Related]
3. Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors.
Rauch B; Niroomand F; Messineo FC; Weis A; Kübler W; Hasselbach W
Biochem Pharmacol; 1994 Sep; 48(6):1289-96. PubMed ID: 7945423
[TBL] [Abstract][Full Text] [Related]
4. Interaction of amiodarone and desethylamiodarone with the cardiac muscarinic receptor in vitro.
Colvin RA; Oibo JA; Allen RA; Tyler L; Leek D
J Mol Cell Cardiol; 1989 May; 21(5):453-60. PubMed ID: 2778804
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.
Yang CM; Farley JM; Dwyer TM
J Auton Pharmacol; 1986 Mar; 6(1):15-24. PubMed ID: 3957950
[TBL] [Abstract][Full Text] [Related]
6. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
Galper JB; Dziekan LC; O'Hara DS; Smith TW
J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
[TBL] [Abstract][Full Text] [Related]
7. Interactions of phospholipids and free fatty acids with antidepressant recognition binding sites in rat brain.
Stockert M; Zieher LM; Medina JH
Adv Exp Med Biol; 1992; 318():325-30. PubMed ID: 1636501
[TBL] [Abstract][Full Text] [Related]
8. Verapamil interaction with the muscarinic receptor: stereoselectivity at two sites.
Gerry RH; Rauch B; Colvin RA; Adler PN; Messineo FC
Biochem Pharmacol; 1987 Sep; 36(18):2951-6. PubMed ID: 3632719
[TBL] [Abstract][Full Text] [Related]
9. Effects of deoxyribonuclease I and neuraminidase treatments on the specific binding of 3H-prazosin and 3H-quinuclidinyl benzilate (3H-QNB) to alpha-adrenergic and muscarinic receptors in rat myocardial membranes.
Nagatomo T; Tsuchihashi H; Imai S
Jpn J Pharmacol; 1986 May; 41(1):135-8. PubMed ID: 3016391
[TBL] [Abstract][Full Text] [Related]
10. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
Taniguchi T; Tsukahara T; Fujiwara M
Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
[TBL] [Abstract][Full Text] [Related]
11. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
Moret C; Pastrie I; Briley M
Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
[TBL] [Abstract][Full Text] [Related]
12. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
13. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
Das S; Matwyshyn GA; Bhargava HN
Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
[TBL] [Abstract][Full Text] [Related]
14. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by local anesthetics, phentolamine and propranolol of [3H]quinuclydinyl benzylate binding to central muscarinic receptors.
Aguilar JS; Criado M; De Robertis E
Eur J Pharmacol; 1980 Dec; 68(3):317-26. PubMed ID: 7202495
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
Mittal CK
Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
[No Abstract] [Full Text] [Related]
17. Comparison of two radiolabeled quinuclidinyl benzilate ligands for the characterization of the human peripheral lung muscarinic receptor.
Joad JP; Casale TB
Life Sci; 1987 Sep; 41(13):1577-84. PubMed ID: 3626772
[TBL] [Abstract][Full Text] [Related]
18. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
19. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective L-[3H]quinuclidinyl benzilate-binding sites in nervous tissue of Aplysia californica: evidence for muscarinic receptors.
Murray TF; Mpitsos GJ; Siebenaller JF; Barker DL
J Neurosci; 1985 Dec; 5(12):3184-8. PubMed ID: 4078624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
